APH vs BRTX · P/E 40, rev $23.09B vs rev $401.0K
Amphenol Corporation (APH) versus BioRestorative Therapies Inc (BRTX) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. BRTX currently screens at market cap $10.2M.
Not investment advice. Open the APH and BRTX stock pages for the full models.
Not investment advice.